Emergent Biosolutions Inc (EBS)
Deferred Revenue
$15.00M
Quarterly · Period ending: · USD
EBS Deferred Revenue
Latest reported$15.00Mperiod ending
Latest reported$15.00Mperiod ending
EBS Quarterly Deferred Revenue ($0.00 → $15.00M)
Quarterly deferred revenue
High-resolution chart · PNG
EBS deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 15,000,000 | |
| 12,200,000 | |
| 0 | |
| 0 | |
| 4,900,000 | |
| 0 | |
| 4,800,000 | |
| 0 | |
| 0 | |
| 5,500,000 | |
| 27,200,000 | |
| 22,900,000 | |
| 14,300,000 | |
| 12,800,000 | |
| 26,400,000 | |
| 24,800,000 | |
| 0 | |
| 0 | |
| 11,700,000 | |
| 36,800,000 | |
| 54,500,000 | |
| 60,300,000 | |
| 0 | |
| 0 | |
| 32,700,000 | |
| 0 | |
| 0 | |
| 107,600,000 | |
| 77,000,000 | |
| 64,700,000 | |
| 10,600,000 | |
| 10,790,000 | |
| 9,750,000 | |
| 6,964,000 | |
| 13,232,000 | |
| 4,509,000 | |
| 15,412,000 | |
| 10,647,000 | |
| 7,036,000 | |
| 4,824,000 | |
| 7,129,000 | |
| 9,589,000 | |
| 7,942,000 | |
| 8,734,000 | |
| 7,343,000 | |
| 5,266,000 | |
| 5,345,000 | |
| 5,813,000 | |
| 5,333,000 | |
| 5,180,000 | |
| 1,834,000 | |
| 2,038,000 | |
| 2,049,000 | |
| 2,008,000 | |
| 1,811,000 | |
| 1,574,000 | |
| 1,504,000 | |
| 283,000 | |
| 1,362,000 | |
| 4,359,000 | |
| 5,336,000 | |
| 5,916,000 | |
| 7,839,000 | |
| 253,000 | |
| 241,000 | |
| 241,000 | |
| 255,000 | |
| 255,000 | |
| 478,000 | |
| 227,000 | |
| 232,000 | |
| 820,000 | |
| 901,000 | |
| 900,000 | |
| 902,000 | |
| 729,000 | |
| 976,000 | |
| 1,090,000 | |
| 1,432,000 | |
| 8,978,000 | |
| 7,340,000 | |
| 18,256,000 | |
| 0 | |
| 0 |